Regulation & Compliance

The Brownie Baker recalls mislabeled muffins with undeclared walnuts, highlighting the life-threatening risks of packaging mistakes in the food industry.

The firm reported a 3.7% drop in net asset value and a net loss for Q1 2026, raising questions about its dividend sustainability despite a stable payout.

On Red Dress Day, Métis leaders passed a sacred trust to PM Carney, demanding an end to funding gaps and real action on the stalled MMIWG2S+ crisis.

Facing financial pressures, the biotech divests a key cancer program, repays debt, and now explores all options to maximize value for its remaining pipeline.

The online therapy giant launches a massive giveback, partnering with the WNBA and nonprofits to address the silent mental health crisis facing mothers.

The media giant posted strong Q3 results, driven by a bold strategy to monetize its content with AI partners while aggressively suing content scrapers.

The institutional crypto exchange is filing for CFTC licenses, a move that could unlock institutional capital and reshape the US digital asset market.

As complex new global AI and data laws take effect, Canadian businesses are scrambling for guidance, fueling a boom in specialized advisory services.

As insurers invest billions in opaque private loans, state and federal officials are coordinating to manage hidden risks for policyholders and the financial system.

Artivion posts strong Q1 results and acquires Endospan for its FDA-approved NEXUS system, yet lowers its full-year guidance. What's behind the mixed message?

Carrington acquires Valon Mortgage and adopts its AI platform, a landmark deal set to redefine the complex world of government mortgage servicing.

AGCO hits two major iGaming suppliers with penalties, sending a clear message about the risks of supplying games to Ontario's unregulated black market.

Forethought founder Deon Nicholas unveils Espa, an AI executive assistant that executes tasks, aiming to democratize productivity for all.

Dr. David Rankey joins Wellvana as CMO, a strategic move as the company scales its model and the industry shifts from proof of concept to performance.

The Italian pharma giant appoints a global health policy heavyweight, signaling a strategic pivot towards tackling complex global challenges and a new era.

A new partnership embeds behavioral health data directly into clinical records, creating a unified patient view and setting a new standard for whole-person care.

Sesen launches a new platform blending AI and human experts to streamline complex medical translation, aiming for faster, safer global market access.

Vancouver's ME Therapeutics will unveil its in-vivo immune reprogramming technology, a potential cancer treatment game-changer, to global investors.

InvestNext's new Transact service integrates a full business bank account into its platform, promising to slash fundraising delays for real estate GPs.

Seattle nonprofit Ryther launches Juniper, an intensive program for teens, addressing a critical gap in care for older adolescents with mood and anxiety.